Bluewater Bio's Series A Round

Bluewater Bio raised a round of funding on August 19, 2008. Investors include Lehman Brothers.

Bluewater Bio is in the wastewater treatment business, providing a wastewater treatment process, called HYBACS. Per the company, HYBACS, denoting Hybrid Bacillus Activated Sludge, treats a wide range …

Articles about Bluewater Bio's Series A Round: